Tag: #M&A

Eli Lilly has officially announced an agreement to acquire Ventyx Biosciences for $14 per share, totaling $1.2 billion. This strategic... Read more

Expanding Oncology Portfolio with Breakthrough Science On December 30, 2025, Johnson & Johnson (J&J) announced the completion of its acquisition... Read more

Strengthening adult immunization strategic assets The French pharmaceutical giant Sanofi has reached a definitive agreement to acquire Dynavax Technologies for... Read more

Strategic takeover deal ahead of the holidays French pharmaceutical giant Sanofi has reached an agreement to acquire Dynavax, a California-based... Read more

AstraZeneca has officially entered into a global licensing agreement worth up to $2 billion for Jacobio Pharma’s Pan-KRAS inhibitor candidate,... Read more

On December 22, Shionogi revealed a definitive agreement to acquire the amyotrophic lateral sclerosis (ALS) portfolio from Tanabe Pharma. The... Read more

Biopharmaceutical giant BioMarin has announced an agreement to acquire Amicus Therapeutics for $4.8 billion. This transaction represents the largest in... Read more

The international biopharmaceutical corporation, Ipsen, successfully concluded its purchase of ImCheck Therapeutics on December 15, 2025, in Paris, France. This... Read more

Gaelic Laboratories, a pharmaceutical manufacturer specializing in Beta-Lactam (penicillin) products, has acquired Athlone Laboratories, a developer and manufacturer of oral... Read more